Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Mumps Measles Rubella Varicella
Agenda & Minutes Chile Influenza
Download:
Recommendation Canada Influenza
Download:
pandemic Position paper Influenza
Download:
Agenda & Minutes United Kingdom COVID-19 Influenza
Download:
Agenda & Minutes United Kingdom Human papillomavirus (HPV) Influenza COVID-19
Download:
Recommendation Belgium Influenza
Download: